Company / Operating Cash Flow per Share
Aligos Therapeutics, Inc. Operating Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.03
FY2025
5-year range
-$26.88 / -$1.03
FY2021-FY2025
Trend
+96.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 6 years, ranging from $-26.88 in FY2024 to $-1.03 in FY2025.
Based on SEC 10-K filings.
-1.03 in FY2025.
Improved from $-1.85 to $-1.03 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 96.2% year-over-year.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.03 | +96.2% |
| FY2024 | -$26.88 | -1353.3% |
| FY2023 | -$1.85 | +31.7% |
| FY2022 | -$2.71 | -39.1% |
| FY2021 | -$1.95 | +83.6% |
| FY2020 | -$11.91 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026